Back to Search Start Over

Omeros Investigational New Drug Application for OMS906 Cleared by FDA

Source :
Legal Monitor Worldwide. September 1, 2020
Publication Year :
2020

Abstract

Omeros Corporation today announced that its Investigational New Drug Application (IND) to begin clinical trials with OMS906 has been cleared by the U.S. Food and Drug Administration (FDA). OMS906 is [...]

Subjects

Subjects :
United States. Food and Drug Administration -- Planning
Monoclonal antibodies
Proteases -- Planning
Biological products -- Planning
Company business planning
Business, international
Law

Details

Language :
English
Database :
Gale General OneFile
Journal :
Legal Monitor Worldwide
Publication Type :
News
Accession number :
edsgcl.634112897

Tools

Authors Abstract Subjects Details